Skip to main content

ORIGINAL RESEARCH article

Front. Med., 05 January 2022
Sec. Nephrology
This article is part of the Research Topic Genetics And Epigenetics of Chronic Kidney Disease View all 17 articles

Robo2 and Gen1 Coregulate Ureteric Budding by Activating the MAPK/ERK Signaling Pathway in Mice

  • 1Department of Nephrology, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Children's Hospital of Fudan University, Shanghai, China
  • 2State Key Laboratory of Genetic Engineering and National Center for International Research of Development and Disease, Collaborative Innovation Center of Genetics and Development, Institute of Developmental Biology and Molecular Medicine, School of Life Sciences, Fudan University, Shanghai, China

Congenital anomalies of the kidney and urinary tract (CAKUT) are some of the most common developmental defects and have a complicated etiology, indicating an interaction of (epi-) genetic and environmental factors. Single gene mutations and copy number variations (CNVs) do not explain most cases of CAKUT, and simultaneous contributions of more than one gene (di-, oligo-, or polygenic effects; i.e., complex genetics) may lead to the pathogenesis of CAKUT. Robo2 plays a key role in regulating ureteric bud (UB) formation in the embryo, with mutations leading to supernumerary kidneys. Gen1 is a candidate gene associated with CAKUT because of its important role in early metanephric development in mice. We established a mouse model with double disruption of Robo2 and Gen1 using a piggyBac transposon and found that double gene mutation led to significantly increased CAKUT phenotypes in Robo2PB/+Gen1PB/+ mouse offspring, especially a duplicated collecting system. Increased ectopic UB formation was observed in the Robo2PB/+Gen1PB/+ mice during the embryonic period. Robo2 and Gen1 exert synergistic effects on mouse kidney development, promoting cell proliferation by activating the GDNF/RET pathway and downstream MAPK/ERK signaling. Our findings provide a disease model for CAKUT as an oligogenic disorder.

Introduction

Congenital anomalies of the kidney and urinary tract (CAKUT) collectively represent a diverse group of structural malformations that occur during embryonic kidney development, including renal hypoplasia/dysplasia, agenesis, multicystic dysplasia, duplex kidney, hydroureters and ureteropelvic junction obstructions (1). CAKUT is caused by defective kidney development. Mouse kidney development begins at E10.5 with formation of the ureteric bud (UB) from the caudal end of the Wolffian duct (WD), which invades the surrounding metanephric mesenchyme (MM) (2). The UB undergoes T-shaped branching at E11.5 and initiates an arborization program of dichotomous branching events, eventually giving rise to the ureteric tree (3). The MM gives rise to both the cap mesenchyme (nephron progenitor cells), which undergoes a balance of self-renewal and differentiation to sequentially form epithelial nephrons (4, 5), and the stromal elements of the final kidney (6).

The development of the kidney and urinary tract is tightly regulated by multiple genes. However, single gene mutations and copy number variations (CNVs) do not explain the majority of sporadic cases of CAKUT, while complex interactions of multiple genetic and environmental factors may explain a substantial proportion of cases (7). Furthermore, even in mouse models, the phenotypes resulting from genetic deletion vary substantially, suggesting that gene-gene and gene-environment interactions contribute to CAKUT (8). Previous research by our team indicated that a low-protein diet synergizes with Robo2 mutation to increase the risk of developmental abnormalities in the mouse urinary system (9). Moreover, some mouse polygenic models of CAKUT, such as Pax2+/−Pax8+/− (8), Hnf1b+/−Pax2+/− (9), and Foxc1+/−Foxc2+/− (10) double heterozygous mice, have been established, suggesting that a haploinsufficient genetic combination will result in the CAKUT phenotype. A previous study reported a patient with renal hypodysplasia (RHD) carrying homozygous missense mutations in both BMP4 (p.N150K) and DACH1 (p.R684C), which provides a model for RHD as an oligo-/polygenic disorder (11). Therefore, CAKUT is likely associated with multiple gene variants.

Several key regulatory genes involved in normal kidney development in humans and mice, including Roundabout Guidance Receptor 2 (ROBO2) and GEN1 Holliday Junction 5′ Flap Endonuclease (GEN1), attracted our attention because they play key roles in early urogenital tract development (1216). ROBO2, as a human CAKUT gene with the OMIM-phenotype number (MIM#610878), a member of the immunoglobulin (Ig) superfamily of cell adhesion molecules (17), binds to its ligand SLIT2 and plays vital roles in maintaining the normal morphogenesis of the kidney. SLIT/ROBO signaling, which is known for its role in axon repulsion, appears to repulse GDNF-expressing cells from the WD, thus causing a physical separation of these two structures in anterior regions (18) and resulting in exposure of the nephrogenic cord to proliferation-inducing signals from which it would normally be shielded by the ureteric mesenchyme. ROBO2 signaling regulates cellular localization by directing the migration of SIX2+ cells; thus, the number of SIX2+ nephron progenitors (NPs) in the nephrogenic cord increases, resulting in an expansion of the GDNF domain (19). In both Slit2 and Robo2 mutants, multiple UBs form anterior to where normal UB outgrowth occurs, and hydroureter and multilobular kidneys are observed (20). In addition, SLIT/ROBO signaling is reportedly involved in regulating branching morphogenesis in the mammary gland and is related to breast cancer development and metastasis (21).

GEN1, a Holliday junction resolvase, is involved in the homologous repair of DNA double strand breaks and in maintaining centrosome integrity (22). GEN1 may play an important role in the development of the mammary gland, as it is likely involved in the DNA damage response of breast cancer cell lines (23). Our team first discovered that Gen1 may be a potential candidate gene associated with CAKUT in mice (15). Gen1 mutation results in kidney abnormalities, including hypoplasia, duplex kidney, hydronephrosis, and the vesicoureteral reflux (VUR), in mice (15). During early kidney development, Gen1 mutation impairs GDNF expression, resulting in defective UB branching during early kidney development. The expression level of the cap mesenchyme marker SIX2 was also decreased in Gen1 mutant kidney primordia, indicating that the smaller cap mesenchyme impaired metanephros differentiation and led to kidney hypoplasia in Gen1 mutants (16).

Both Robo2 and Gen1 are involved in kidney development by regulating the GDNF/RET pathway, thus affecting ureteric budding and the development of the nephron progenitors. Together, these observations prompted us to assess whether Robo2 and Gen1 cooperate in a common signaling pathway during mouse kidney development in vivo. Therefore, in the present study, we established a mouse model with Robo2 and Gen1 double mutations to observe postnatal urinary malformations and early-stage kidney developmental abnormalities and investigate whether double gene mutations increase the incidence of CAKUT and the underlying mechanism.

Materials and Methods

Mice

Gen1PB/+ mice were obtained by using PB transposon-based insertional mutagenesis targeted to intron 2 of Gen1 (Chr: 12.11268138, Ensembl: ENSMUSG00000051235). Robo2PB/+ mice were also obtained through PB transposon-based insertional mutagenesis targeted to intron 1 of the Robo2 gene (Chr: 16.74379623, Ensembl: ENSMUSG00000052516). Gen1PB/+ and Robo2PB/+ mice were mated with Hoxb7/myr-Venus mice to obtain Gen1 and Robo2 PB insertion mice specifically expressing fluorescent protein in the UB epithelium (Gen1PB/+;Hoxb7/myr-Venus abbreviated as Gen1PB/+;Hoxb7 and Robo2PB/+; Hoxb7/myr-Venus abbreviated as Robo2PB/+; Hoxb7). Gen1PB/+;Hoxb7 mice were mated with Robo2PB/+;Hoxb7 mice to obtain Gen1PB/+ Robo2PB/+;Hoxb7, Gen1PB/+;Hoxb7, Robo2PB/+;Hoxb7 and WT mice. We observed the phenotypes of the mice urinary system by selecting the same nest of different genotypes. All mice used in the experiments were specific pathogen-free (SPF) and were maintained at 18–22°C and 50–60% humidity on a 12 h day/night cycle. Animals were maintained and managed according to the animal welfare and usage management regulations of the School of Life Sciences of Fudan University [Protocol Approval No. SYXK (hu) 2020–0011]. All mouse strains were maintained on an FVB/N background.

Histological Analyses

Hematoxylin and eosin (H&E) staining was carried out on 7 μm paraffin sections, and performed according to the standard protocols described in the literature (24).

Quantitative Real-Time PCR

Total RNA was extracted from E12.5 using TRIzol (Life Technologies, United States). Total RNA was extracted from kidney primordia of E10.5 embryos using a RNeasy mini kit (Qiagen, Germany). The purity of the RNA was confirmed by measuring the ratio of optical densities at 260 nm/280 nm. Aliquots of total RNA (1.0 μg each) from each sample were reverse transcribed into cDNAs according to the instructions of the PrimeScript® RT Reagent Kit (TaKaRa, China). Amplification was performed using AceQ qPCR SYBR Green Master Mix (Vazyme, China) and a real-time qPCR system (Agilent Mx3000P, United States). Gapdh was used as the internal control. All primers were obtained from the NCBI GenBank database and were synthesized by Genewiz (Shanghai, China). The primers used for RT-PCR were as follows (5′-3′): Gen1-F: 5′-GCCTGGAGTTGGAAAGGAACAAG-3′, Gen1-R: 5′-GGAACACACAGAGCAGTGAACCAC-3′; Robo2-F: 5′-GCGGATCTTTATTCTTTTTGCG-3′, Robo2-R: 5′-TCCTTTTTCCAGTAGATGGTTG-3′; Gdnf-F: 5′- GAACCAAGCCAGTGTATCTCCT-3′, Gdnf-R: 5′-ATCGTCTCTGCCTTTGTCCTC-3′; Ret-F: 5′-TGGCACACCTCTGCTCTATG-3′, Ret-R: 5′-GATGCGGATCCAGTCATTCT-3′; Grem1-F: 5′-CCTTTCAGTCTTGCTCCTTCTGC-3′, Grem1-R: 5′-TTCTTCTTGGTGGGTGGCTGTAGC-3′; Bmp4-F: 5′-GCAAGTTTGTTCAAGATTGGCTCC-3′, Bmp4-R: 5′-CCATCAGCATTCGGTTACCAGG-3′; Bmp2-F: 5′-CACACAGGGACACACCAACC-3′, Bmp2-R: 5′-CAAAGACCTGCTAATCCTCAC-3′; Six2-F: 5′- AGTCCGACGTGATGTGAAC-3′, Six2-R:5′-AGAGAAATGAGAATTCAGGTGC-3′; Foxc1-F: 5′-GCCAAATGGAATGGAACCCC-3′, Foxc1-R: 5′-CGCTGGTGTGAGGAATCTTCTC-3′; Slit2-F: 5′-CCTGTGATGATGGAAATGATGAC-3′, Slit2-R: 5′-CCACTGTATCCAAGCAGGT-3′; and Gapdh-F: 5′-TGTTCCTACCCCCAATGTGTCC-3′, Gapdh-R: 5′-GGAGTTGCTGTTGAAGTCGCAG-3′. The relative gene expression levels were calculated using the 2−ΔΔCT method. Each group contained at least three samples, and each sample was assayed in triplicate.

Phenotype Analysis

After the newborn mice in each group were anesthetized with CO2, the abdomen was exposed along the midline incision of the anterior abdominal wall. Liver and intestinal tissues were removed to make sure that the urinary systems of the mice were fully exposed. The sex of the mice was determined under a fluorescence stereoscope, and the location, morphology, number of kidneys, ureters and bladders in the newborn pups from each group were observed. Pregnant mice were anesthetized at E11, E11.5 and E12.5 using CO2. The abdomen of the mice was fully exposed, and the uteri were separated. The placenta and fetal membranes of the mice were removed under a stereoscope. The mouse embryos were flattened, limbs, intestines and liver were removed, and the bean-shaped tissue near the spinal column on the posterior abdominal wall was identified as early embryonic kidney tissue. The location and number of UBs were observed. The images were recorded under a microscope (Leica, Germany).

Whole Mount Immunofluorescence Staining

Embryos were dissected at E11.5 and fixed in 4% paraformaldehyde solution (PFA) (pH 7.4) at 4°C overnight. After the tissues were soaked in PBS/1% Triton X-100 for 20 min and rinsed with PBS several times, they were blocked with PBS (0.3% Triton X-100, 5% normal donkey serum and 1x PBS) overnight at 4°C. The tissues were incubated overnight at 4°C with primary antibodies against phospho-ERK (Cell Signaling Technology, 4,370; 1:100), phospho-AKT (Cell Signaling Technology, 8,272; 1:100), and phospho-PLCγ (Cell Signaling Technology, 8,713; 1:100). The tissues were washed 3 times with PBS for 30 min each, incubated with Cy5-conjugated donkey anti-rabbit secondary antibody (Jackson, 1:500) overnight at 4°C and washed several times with PBS. Images of stained tissue were captured using a Zeiss-LSM880 with Airyscan confocal laser scanning microscope and ZEN ImageJ software (Zeiss, Germany). The details about how the measurements were conducted on the confocal images are described in the literature (25). ImageJ was used to quantify the amount of fluorescence as mean gray value of pERK, pAKT, PLCγ and compare the results among four groups. ImageJ was also used to determine the number of stained cells by phosphorylation of histone H3 (PHH3) to compare the results among these groups.

Statistics

All data were processed using STATA 16.0 statistical software. The data are presented as the means ± SEM. The differences between two groups were determined with an unpaired t-test or Fisher's exact test. The significance level was set to P < 0.05.

Results

Decreased Robo2 and Gen1 Expression in the Robo2PB/+Gen1PB/+ Mutant Mice

The insertion of a piggyBac (PB) transposon into the second intron of the mouse Gen1 gene and the first intron of the Robo2 gene significantly disrupted their expression. We analyzed the expression of Robo2 and Gen1 in the control and mutant mice on E12.5 using RT-PCR. In the whole embryos of the Robo2PB/+Gen1PB/+ mutant mice, Robo2 expression significantly decreased by 41% compared with that in the WT mice (P < 0.0001), but Robo2 expression was not different from that in the Robo2PB/+ mutant mice. In the whole embryos of the Robo2PB/+Gen1PB/+ mutant mice, the expression level of Gen1 was significantly decreased by 53% compared with that in the WT mice (P < 0.0001), but its expression was not different from that in Gen1PB/+ mutant mice (Figure 1A).

FIGURE 1
www.frontiersin.org

Figure 1. Expression of Robo2 and Gen1 in the WT, Robo2PB/+, Gen1PB/+ and Robo2PB/+Gen1PB/+ mice. (A) Expression levels of Gen1 and Robo2 in E12.5 whole WT, Robo2PB/+, Gen1PB/+, and Robo2PB/+Gen1PB/+ mouse embryos. N = 3 WT, Robo2PB/+ and Robo2PB/+Gen1PB/+ embryos each; N = 5 Gen1PB/+ embryos. (B) Expression levels of Gen1 and Robo2 in kidneys from E11.5 WT, Robo2PB/+, Gen1PB/+ and Robo2PB/+Gen1PB/+ mice. N = 4 mice each in the four groups. Data are presented as the means ± SEM. NS, nonsignificant; *P < 0.05; **P < 0.001; ***P < 0.0001.

We also analyzed the expression of Robo2 and Gen1 in the embryonic kidney tissue on E11.5. Robo2 was expressed at lower levels in embryonic kidney tissue from the Robo2PB/+Gen1PB/+ mutant mice than in the WT mice (P < 0.0001) and the Robo2PB/+ mutant mice (P = 0.002). Lower expression of Gen1 was detected in the embryonic kidney tissue of the Robo2PB/+Gen1PB/+ mutant mice than in the WT mice (P = 0.004) and the Gen1PB/+ mutant mice (P = 0.03) (Figure 1B).

Increased Presentation of CAKUT Phenotypes in the Neonatal Robo2PB/+Gen1PB/+ Mutants

Ninety-six newborn Robo2PB/+Gen1PB/+ mice were grossly dissected for a comprehensive analysis of the urinary system. The number of mice used in each group was listed in a table (Supplementary Table 1). The incidence of CAKUT in the neonatal period was 32.3%, which was higher than that in the Robo2PB/+ group [32.3% (31/96) vs. 13.6% (3/22), P = 0.01] and in the Gen1PB/+ group [32.3% (31/96) vs. 17.3% (9/52), P = 0.038] (Figure 2A). Among these CAKUT phenotypes, the incidence of duplex kidney was increased in Robo2PB/+Gen1PB/+ newborn mice compared with the Robo2PB/+ group [30.2% (29/96) vs. 4.5% (1/22), P = 0.017] and the Gen1PB/+ group [30.2% (29/96) vs. 13.5% (7/52), P = 0.045] (Figure 2B). Five percent (1/20) of the WT newborn mice showed duplex kidneys. The incidence of duplex kidney, renal dysplasia (Supplementary Figure 1A) and hydronephrosis (Supplementary Figure 1B) was 4.5% (1/22) in the Robo2PB/+ neonatal mice. Thirteen percent (7/52) of the Gen1PB/+ newborn mice showed duplex kidneys, and 3.8% (2/52) of the mice showed hydronephrosis (Figure 2B). The CAKUT phenotype (Figures 2C–E#) of the Robo2PB/+Gen1PB/+ mice included isolated duplex kidneys (30.2%, 29/96, Figures 2D,D#) and hydronephrosis complicated with duplex kidneys [2.1%, (2/96), Figures 2E,E#], with isolated duplex kidneys being the most common phenotype. No sex or site preference was observed.

FIGURE 2
www.frontiersin.org

Figure 2. Analysis of newborn mouse phenotypes in the four groups at P0.5. (A) Summary of the kidney symptoms in the four groups. (B) Percentages of newborn mice with a number of normal kidneys (NK), duplex kidneys (DK), hydronephrosis (HN), unilateral renal agenesis (URA) and hydronephrosis complicated with duplex kidneys (HN & DK). The number n represents the number of cases. (C–E) Representative images of the normal kidney (C), duplex kidney (D), and hydronephrosis complicated with duplex kidney (E). (C#–E#) Representative images visualized by staining for Hoxb7 expression in normal kidneys (C#), duplex kidneys (D#), and hydronephrosis complicated with duplex kidneys (E#). Red arrowheads in (D–E#) indicate abnormal nephrogenic zones of the duplex kidney and double ureters. White arrows indicate the normal ureter. (F,G) Histological sections of P0.5 Robo2PB/+Gen1PB/+ (F) and WT kidneys (G) stained with hematoxylin and eosin. The region where nephrogenesis occurs (nephrogenic zone) indicated by black lines is restricted to the periphery in the WT kidney but extends toward the inner cortex of the Robo2PB/+Gen1PB/+ kidney. Scale bars, 2 mm in (C–E#); 200 μm in (F,G). NK, normal kidney; DK, duplex kidney; URA, unilateral renal agenesis; HN, hydronephrosis; Bl, bladder; Ki, kidney; Ur, ureter; Nz, nephrogenic zone; NS, non-significant; *P < 0.05; **P < 0.001.

In the duplex kidney, the nephrogenic zone where new nephrons are being generated, which is normally restricted to the periphery of the developing kidney (Figure 2F), extended toward the inner cortex of the mutant kidneys (Figure 2G).

We also examined urinary tract defects in 36 newborn Robo2PB/+Gen1PB/+ mice and confirmed VUR in nine mutant mice. Three refluxes were observed in all 22 Gen1PB/+ newborn mice, and only one of the 10 Robo2PB/+ mutant mice had confirmed VUR. In the mutant mice with VUR, we observed methylene blue reflux to the renal pelvis and no significant renal pelvic or ureteral dilatation. However, no significant difference in the proportion of VUR was observed among these three groups (Supplementary Figure 1).

Duplex Kidneys Arise From Defective Kidney Induction in the Robo2PB/+Gen1PB/+ Mutants

Excessive UB formation was reported to cause duplex kidneys. Hoxb7/myr-Venus specifically expresses a fluorescent protein in the UB epithelium. We introduced Robo2 and Gen1 mutations in Hoxb7 transgenic mice by breeding to visualize the morphology of the UB in mutant mice, and the UB and nephric ducts were positive for green fluorescence. From E11–E12.5, when the UB invaded the MM, abnormal ectopic budding from the WD was observed (Figure 3, compare D–F with A–C). The Robo2PB/+ and Gen1PB/+ mutant embryos had a single UB at the typical T-stage (E11.5), whereas the Robo2PB/+Gen1PB/+ mutants frequently showed ectopic budding that had already branched from the main UB. No ectopic budding was observed in any of the 32 WT mice or in any of the 24 Robo2PB/+ embryonic control mice. Three percent (1/33) of the Gen1PB/+ mutant kidneys showed ectopic budding compared with 26.8% (11/41) of the Robo2PB/+Gen1PB/+ kidneys (0/32 vs. 11/41, P = 0.002; 0/24 vs. 11/41, P = 0.005; 1/33 vs. 11/41, P = 0.005). The proportion of unilateral ectopic budding in Gen1PB/+ kidneys was 1/33 (3.0%) compared with 22.0% (9/41) in Robo2PB/+Gen1PB/+ kidneys (0/32 vs. 9/41, P = 0.001; 0/24 vs. 9/41, P = 0.003; 1/33 vs. 9/41, P = 0.018) (Figure 3G), suggesting that Robo2 and Gen1 may synergistically regulate ureteric budding to prevent duplex kidney formation.

FIGURE 3
www.frontiersin.org

Figure 3. Comparison of ureteric budding in the four groups. (A–F) Staining of whole mounts of the Robo2PB/+Gen1PB/+ mutants at E11 (A), E11.5 (C), and E12.5 (E) visualized using Hoxb7/myr-Venus expression shows abnormal ectopic ureteric budding compared with the single normal UB observed in the WT mice (B,D,F). (G) Summary of the ectopic budding incidence in the WT, Robo2PB/+, Gen1PB/+, and Robo2PB/+Gen1PB/+ kidneys. The ectopic budding incidence is shown as the number of kidneys with ectopic budding or branching/total number of kidneys examined. Uni, Unilateral; Bi, Bilateral. Scale bars represent 100 μm in A-D. Scale bars represent 200 μm in E-F. NS, non-significant; **P < 0.001.

GDNF/RET Signaling Is Enhanced in the Robo2PB/+Gen1PB/+ Mutants

The Robo2PB/+Gen1PB/+ mutants displayed several phenotypes that may be caused by increased GDNF/RET signaling. We examined the expression of Gdnf and Ret in embryonic kidney tissues at E11.5 using RT-PCR to determine whether RET signaling is increased in the Robo2PB/+Gen1PB/+ mutants. Compared with the WT mice, Gdnf expression was decreased in the Gen1PB/+ mutant mice (P = 0.03), significantly increased both in the Robo2PB/+ mutant mice (P < 0.001), and in the Robo2PB/+Gen1PB/+ mutant mice (P < 0.001). Ret expression was significantly increased in the Robo2PB/+, Gen1PB/+ and Robo2PB/+Gen1PB/+ (P < 0.001) mutant mice (Figure 4A).

FIGURE 4
www.frontiersin.org

Figure 4. GDNF/RET signaling is increased in the Robo2PB/+Gen1PB/+ mutants during metanephric development. (A) Changes in Gdnf and Ret expression in kidneys from the E11.5 WT, Robo2PB/+, Gen1PB/+ and Robo2PB/+Gen1PB/+ mice, N = 3. (B) Changes in the expression of key genes involved in metanephric development at E11.5, N = 3. (C) Immunofluorescence staining with antibodies against pERK in the kidneys of the WT, Robo2PB/+, Gen1PB/+, Robo2PB/+Gen1PB/+ mice at E11.5. N = 3, original magnification × 10. (D) Immunofluorescence staining with antibodies against PHH3 in the kidneys of the WT, Robo2PB/+, Gen1PB/+, Robo2PB/+Gen1PB/+ mice at E11.5. N = 4, original magnification × 10. Scale bars represent 100 μm in (C,D). *P < 0.05; **P < 0.001.

Then, we detected the expression of genes involved in regulating the GDNF/RET signaling axis and causing duplex kidney: Gremlin (Grem1), Bmp4, Bmp2, Six2, Foxc1, Slit2 and Sox11. Among them, Grem1 expression was increased in the Gen1PB/+ mutant mice (P = 0.008) but not in the Robo2PB/+ mutant mice. Grem1 expression was increased in the Robo2PB/+Gen1PB/+ mutant mice (P = 0.04), while both Bmp2 and Bmp4 expression levels were markedly decreased in the Robo2PB/+Gen1PB/+ mutant mice (P < 0.001). Bmp2 was also reduced in the Gen1PB/+ mutant mice (P = 0.04). Slit2 expression was significantly increased in the Robo2PB/+ mutant mice compared with the WT mice (P < 0.001), but not in the Gen1PB/+ and Robo2PB/+Gen1PB/+ mutant mice. Six2, Foxc1, Slit2, and Sox11 expression levels were not changed in the four groups (Figure 4B).

We examined the phosphorylation of a downstream effector, ERK. pERK has a wide range of both cytosolic and nuclear targets and functions, and its level reflects MAPK signaling downstream of RET. We also examined the phosphorylation of two other downstream effectors, AKT and PLCγ, which are both involved in RET intracellular signaling cascades. The pERK level was significantly increased in the UB and its surrounding nephrogenic cord cells in the E11.5 Robo2PB/+Gen1PB/+ kidneys compared with the WT (P = 0.0014), Robo2PB/+ (P = 0.0069), and Gen1PB/+ kidneys (P = 0.0015) (Figure 4C). However, we were unable to detect alterations in pAKT and pPLCγ levels in E11.5 kidneys (Supplementary Figure 2). The MAPK pathway, which involves the ERK1/2 cascade, is activated by various stimuli and contributes to the regulation of proliferation, differentiation, and cell survival.

We detected the expression of the RET transcription factor Etv5 to determine whether MAPK/ERK signaling was upregulated in Robo2PB/+Gen1PB/+ mutants. We found increased expression of Etv5 at E12.5, when the ureteric buds were undergoing repeated branching events (Supplementary Figure 3). We also determined the level of PHH3, which is an indicator of mitosis. Importantly, in the E11.5 Robo2PB/+Gen1PB/+ kidney sections, PHH3 levels were significantly increased compared with the WT (P < 0.001), Robo2PB/+ (P = 0.0005), and Gen1PB/+ groups (P < 0.001) (Figure 4D).

Discussion

In this study, we showed that double heterozygous mutation for Robo2 and Gen1 led to significantly increased CAKUT phenotypes, particularly a duplicated collecting system, indicating a genetic interaction between the two genes. Furthermore, compound heterozygosity results in more ectopic UBs and cell proliferation through the activation of the GDNF/RET pathway and downstream MAPK/ERK cascade.

In our study, the Robo2PB/+Gen1PB/+ mice exhibited an aggravation of the CAKUT phenotype, and the incidence of CAKUT was higher than that in the Robo2PB/+ and Gen1PB/+ mice. In addition, the phenotypic distribution of the Robo2PB/+Gen1PB/+ mice was relatively concentrated, and duplex kidneys were mainly observed. The proportion of ectopic buds detected in the embryonic stage of mice with double gene mutations was significantly increased. The expression of Robo2 and Gen1 in the embryonic kidney of Robo2PB/+Gen1PB/+ mutant mice, but not in general in whole embryos, was lower than that in Robo2PB/+ and Gen1PB/+ mice, suggesting that Gen1 and Robo2 may have interaction and Gen1 expression seems to depend on Robo2 expression during kidney development. GDNF expression was decreased at E11.5 in the Gen1PB/+ mutant mice, increased in the Robo2PB/+ mutant mice, and significantly increased in the Robo2PB/+Gen1PB/+ mutant mice. The expression level of RET was increased in the Robo2PB/+, Gen1PB/+ and Robo2PB/+Gen1PB/+ mutant mice. According to Grieshammer et al. (18), the primary function of SLIT2/ROBO2 signaling during kidney development is to ensure that GDNF expression becomes localized to the region where the UB normally forms, thereby restricting kidney induction to the appropriate site. Therefore, we speculated that Robo2 and Gen1 may work together to regulate the GDNF/RET signaling pathway and play a synergistic role in promoting the expression of RET.

In general, the WD does not respond to the GDNF signal in anterior regions, and two potential explanations have been proposed (26). First, SLIT/ROBO signaling is known for its role in axon repulsion (21) and appears to repulse GDNF-expressing cells from the WD, resulting in a physical separation of these two structures in the anterior regions (19). Second, the anterior intermediate mesoderm (IM) exhibits relatively high levels of BMP signaling, which is thought to be an antagonist that suppresses ureter branching in kidney development (27). Heterozygous Bmp4 mutations in mice lead to a variety of CAKUT phenotypes, including duplex kidneys (28).

In the Robo2PB/+Gen1PB/+ mutant mice, Gen1 expression was reduced, accompanied by an increase in the expression of Grem1, consistent with previous studies (15). Previous studies found that both GREM1 and ROBO2 bind to the same domain of SLIT2 (29, 30). However, the affinity of ROBO2 for the N-terminal fragment of SLIT2 (SLIT2N) is much higher than that of GREM1 (31, 32). A high local concentration of GREM1 is needed to overcome the stronger interaction between SLIT2 and ROBO2. This finding has been verified in neurons, in which only high concentrations of GREM1 block SLIT2-mediated inhibition of neuronal migration. Therefore, GREM1 expression increased, which might result in competitive inhibition with ROBO2, reducing the binding between ROBO2 and SLIT2 (30). This effect may be exacerbated by the presence of a reduction in Robo2 expression in the Robo2PB/+Gen1PB/+ mutant mice. GEN1 may interact with the ROBO2/SLIT2 signaling pathway through GREM1, thereby affecting the expression of GDNF/RET, but its specific mechanism remains to be further confirmed.

MM cells express the BMP inhibitor GREM1, which counteracts BMP function, to permit ureter outgrowth specifically at the proper site of the kidney (33). Both BMP2 and BMP4 are important members of the BMP signaling pathway. An in vitro kidney organogenesis experiment has shown that BMP2 treatment of cells causes a significant decrease in GDNF and GFRα1 mRNA expression during differentiation from the posterior intermediate mesoderm stage to the metanephric mesenchyme (days 7–9) (30). In the Robo2PB/+Gen1PB/+ mutant mice, the increase in Grem1 expression was accompanied by a decrease in BMP expression. Thus, we speculated that the increase in Grem1 expression exerted an enhanced inhibitory effect on the BMP signaling pathway, which may lead to a decreased inhibitory effect of BMP2 and BMP4 on RET in the WD. Direct negative crosstalk between the SLIT2 and BMP-Gremlin signaling pathways has also been observed. A previous study revealed a negative feedback loop in fibroblasts in which SLIT2 inhibits GREM1 activity and BMP downregulates Slit2 expression by suppressing Slit2 promoter activity through canonical BMP signaling pathways (30). Through the negative crosstalk between these molecules, an interaction network was formed between Robo2 and Gen1. We speculated that the combined actions of several molecules increase the expression of GDNF and RET.

As the major inducers of RET signaling in the early developing kidney, GDNF binding to its cognate receptors causes activation of intracellular signaling cascades, including the PI3K/AKT, RAS/MAPK and PLCγ/Ca2+ pathways (34). The MAPK/ERK pathway appears to be closely related to ureter branching, and mice lacking the MEK1 and MEK2 kinases do not form an appropriately branched ureteric tree (35). In the present study, we observed increased levels of pERK, which reflects MAPK signaling, in both the UB and its surrounding nephrogenic cord cells, while the levels of pAKT and pPLCγ were not changed in compound heterozygous mice. A previous study reported that Etv5 expression requires activation of the MEK/ERK (MAPK) signaling pathway in neurons (36). Significantly, in E12.5 Robo2PB/+Gen1PB/+ kidney sections, Etv5 expression was increased in the UB tips. A previous study showed that MAPK/ERK activity regulates proliferation in UBs to achieve normal branching and growth (35). As a transcription factor, ETV5 is also dispensable for the cellular self-renewal ability (37). As the PHH3 occurs in late G2 and M phase of the cell cycle, it serves as a specific marker for cells undergoing mitosis (38). In this study, we detected the expression level of PHH3 and observed increased levels in double mutant mice. Therefore, we speculated that cell mitosis may be promoted through the activation of the downstream MAPK/ERK cascade, resulting in increased cell proliferation and finally the formation of ectopic UBs (Figures 5A,B).

FIGURE 5
www.frontiersin.org

Figure 5. Molecular regulation of ureteric budding and branching morphogenesis. (A) In wild-type mice, GEN1 may inhibit GREM1 expression, and GREM1 counteracts BMP signaling. Additionally, direct negative cross-talk is observed between SLIT2 and BMP2-Gremlin signaling. BMP2, BMP4 and ROBO2 inhibit GDNF signal transduction, inhibiting budding and subsequent branching of the ureter via RET and GFRα1, thereby restricting kidney induction to the appropriate site. (B) In Robo2PB/+Gen1PB/+ mice, decreased GEN1 expression led to increased GREM1 expression, and the high local concentration of GREM1 competitively inhibited ROBO2, reducing the binding between ROBO2 and SLIT2. Prior to UB induction, the nephrogenic cord itself is expanded due to the reduced repulsion between ROBO2 and SLIT2 relative to wild-type. In contrast, the increase in Grem1 expression exerted an enhanced inhibitory effect on the BMP signaling pathway, which may lead to the decreased inhibitory effect of BMP2 and BMP4 on RET in the WD. At the molecular level, RET is activated and recruited by GFRα1 and GDNF and subsequently activates downstream MAPK/ERK signaling and cell proliferation. As RET transcription factor, Etv5 reflects the activation of MAPK/ERK signaling, driving ectopic UB induction in more anterior metanephric/caudal mesonephric regions. Gen1 and Robo2 may exert a synergistic effect on activating the GDNF/RET pathway. WD, Wolffian duct; MM, metanephric mesenchyme; UM, ureteric mesenchyme; UB, ureteric bud; BMPs, BMP2 and BMP4.

In our study, pERK levels were increased in the UB and its surrounding nephrogenic cord cells in E11.5 Robo2PB/+Gen1PB/+ kidneys. In addition to regulating the UB epithelium, the MAPK/ERK pathway might also participate in the regulation of nephrogenesis, which has multiple functions in the guidance of nephron differentiation (34). NP-specific MAPK inactivation results in an almost complete lack of nephrons in newborn mouse pups (34, 39). Therefore, we speculate that ROBO2 and GEN1 not only coregulate ureteric budding but also exert some common effect on the nephrogenic cord through the activation of the cap mesenchyme marker SIX2 or MAPK/ERK signaling. Further studies are needed to address the combined effects of ROBO2 and GEN1 on nephron progenitor biology and the cap mesenchyme.

The specific interaction between Gen1 and Robo2 remains unclear. One interpretation of our results is that Gen1 may interact with the ROBO2/SLIT2 pathway through Grem1. The different affinities of ROBO2 and GREM1 for SLIT2N may play a specific role in metanephric kidney development. The current data do not allow us to discriminate between these possibilities, which would require a detailed analysis of GREM1 and ROBO2. In addition, further studies will be required to search for mutation sites in the two genes in patients with CAKUT and to clarify their role in the development of the human kidney.

This finding is consistent with the recent understanding of CAKUT as an oligomeric/polygenic disorder that may be caused by the accumulation of multiple subtle mutations or polymorphisms (mutational load) that lead to dysfunction of the corresponding developmental program (40). Although some aspects of the roles of Gen1 and Robo2 in metanephros development remain to be clarified, our results unambiguously identified a cooperative role for Gen1 and Robo2 in metanephric budding.

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Ethics Statement

The animal study was reviewed and approved by School of Life Sciences of Fudan University [Protocol Approval No. SYXK (hu) 2020-0011].

Author Contributions

XW, HX, and QS conceived and designed research. YL performed experiments, analyzed data, and drafted the manuscript. MY, LT, SX, and XD interpreted results of experiments. YL, MY, and LT prepared figures. QS edited and revised the manuscript and approved final version of the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the National Natural Science Foundation of China (81670609 and 81900602) and the Establishment, Performance, and Quality Control of the Standardized Phenotype Analysis Process Grant (No. 2018YFA0801102).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2021.807898/full#supplementary-material

References

1. Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J. Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet. (2002) 266:163–7. doi: 10.1007/s00404-001-0265-4

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Short KM, Smyth IM. The contribution of branching morphogenesis to kidney development and disease. Nat Rev Nephrol. (2016) 12:754–67. doi: 10.1038/nrneph.2016.157

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Costantini F, Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Developmental cell. (2010) 18:698–712. doi: 10.1016/j.devcel.2010.04.008

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell. (2008) 3:169–81. doi: 10.1016/j.stem.2008.05.020

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Short KM, Combes AN, Lefevre J, Ju AL, Georgas KM, Lamberton T, et al. Global quantification of tissue dynamics in the developing mouse kidney. Dev Cell. (2014) 29:188–202. doi: 10.1016/j.devcel.2014.02.017

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol. (2010) 176:85–97. doi: 10.2353/ajpath.2010.090517

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Nicolaou N, Renkema KY, Bongers EM, Giles RH, Knoers NV. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol. (2015) 11:720–31. doi: 10.1038/nrneph.2015.140

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Narlis M, Grote D, Gaitan Y, Boualia SK, Bouchard M. Pax2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol. (2007) 18:1121–9. doi: 10.1681/ASN.2006070739

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Paces-Fessy M, Fabre M, Lesaulnier C, Cereghini S. Hnf1b and Pax2 cooperate to control different pathways in kidney and ureter morphogenesis. Hum Mol Genet. (2012) 21:3143–55. doi: 10.1093/hmg/dds141

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Motojima M, Tanimoto S, Ohtsuka M, Matsusaka T, Kume T, Abe K. Characterization of kidney and skeleton phenotypes of mice double heterozygous for foxc1 and foxc2. Cells Tissues Organs. (2016) 201:380–9. doi: 10.1159/000445027

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Schild R, Knuppel T, Konrad M, Bergmann C, Trautmann A, Kemper MJ, et al. Double homozygous missense mutations in DACH1 and BMP4 in a patient with bilateral cystic renal dysplasia. Nephrol Dial Transplant. (2013) 28:227–32. doi: 10.1093/ndt/gfs539

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Yu M, Tan L, Li Y, Chen J, Zhai Y, Rao J, et al. Intrauterine low-protein diet aggravates developmental abnormalities of the urinary system via the Akt/Creb3 pathway in Robo2 mutant mice. Am J Physiol Renal Physiol. (2020) 318:F43–f52. doi: 10.1152/ajprenal.00405.2019

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Zhang Y, Zhang X, Wang X, Wang H, Wu X, Xu H, et al. Gen1 modulates metanephric morphology through retinoic acid signaling. DNA Cell Biol. (2019) 38:263–71. doi: 10.1089/dna.2018.4426

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Liu J, Sun L, Shen Q, Wu X, Xu H. New congenital anomalies of the kidney and urinary tract and outcomes in Robo2 mutant mice with the inserted piggyBac transposon. BMC Nephrol. (2016) 17:98. doi: 10.1186/s12882-016-0308-5

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Wang H, Zhang C, Wang X, Lian Y, Guo B, Han M, et al. Disruption of Gen1 causes congenital anomalies of the kidney and urinary tract in mice. Int J Biol Sci. (2018) 14:10–20. doi: 10.7150/ijbs.22768

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Wang X, Wang H, Liu J, Gong Y, Zhang C, Fang F, et al. Gen1 mutation caused kidney hypoplasia and defective ureter-bladder connections in mice. Int J Biol Sci. (2020) 16:1640–7. doi: 10.7150/ijbs.42855

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Kidd T, Brose K, Mitchell KJ, Fetter RD, Tessier-Lavigne M, Goodman CS, et al. Roundabout controls axon crossing of the CNS midline and defines a novel subfamily of evolutionarily conserved guidance receptors. Cell. (1998) 92:205–15. doi: 10.1016/S0092-8674(00)80915-0

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Grieshammer U, Le M, Plump AS, Wang F, Tessier-Lavigne M, Martin GR. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell. (2004) 6:709–17. doi: 10.1016/S1534-5807(04)00108-X

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Wainwright EN, Wilhelm D, Combes AN, Little MH, Koopman P. ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. Dev Biol. (2015) 404:88–102. doi: 10.1016/j.ydbio.2015.05.023

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Brose K, Tessier-Lavigne M. Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr Opin Neurobiol. (2000) 10:95–102. doi: 10.1016/S0959-4388(99)00066-5

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Blockus H, Chédotal A. Slit-Robo signaling. Development. (2016) 143:3037–44. doi: 10.1242/dev.132829

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Ip SC, Rass U, Blanco MG, Flynn HR, Skehel JM, West SC. Identification of holliday junction resolvases from humans and yeast. Nature. (2008) 456:357–61. doi: 10.1038/nature07470

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Sun L, Zhang Y, Pan Z, Li B, Sun M, Zhang X. Expression and localization of GEN1 in mouse mammary epithelial cells. J Biochem Mol Toxicol. (2014) 28:450–5. doi: 10.1002/jbt.21584

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet. (1999) 23:113–7. doi: 10.1038/12722

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Zucker RM, Hunter ES 3rd, Rogers JM. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods. (1999) 18:473–80. doi: 10.1006/meth.1999.0815

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Kozlov VM, Schedl A. Duplex kidney formation: developmental mechanisms and genetic predisposition. F1000Res. (2020) 9:F1000 Faculty Rev-2. doi: 10.12688/f1000research.19826.1

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Motamedi FJ, Badro DA, Clarkson M, Lecca MR, Bradford ST, Buske FA, et al. WT1 controls antagonistic FGF and BMP-pSMAD pathways in early renal progenitors. Nat Commun. (2014) 5:4444. doi: 10.1038/ncomms5444

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest. (2000) 105:863–73. doi: 10.1172/JCI8256

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Howitt JA, Clout NJ, Hohenester E. Binding site for Robo receptors revealed by dissection of the leucine-rich repeat region of Slit. Embo j. (2004) 23:4406–12. doi: 10.1038/sj.emboj.7600446

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Tumelty KE, Higginson-Scott N, Fan X, Bajaj P, Knowlton KM, Shamashkin M, et al. Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways. J Biol Chem. (2018) 293:3039–55. doi: 10.1074/jbc.M117.804021

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell. (1999) 96:795–806. doi: 10.1016/S0092-8674(00)80590-5

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Nguyen Ba-Charvet KT, Brose K, Ma L, Wang KH, Marillat V, Sotelo C, et al. Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance. J Neurosci. (2001) 21:4281–9. doi: 10.1523/JNEUROSCI.21-12-04281.2001

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Michos O, Gonçalves A, Lopez-Rios J, Tiecke E, Naillat F, Beier K, et al. Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis. Development. (2007) 134:2397–405. doi: 10.1242/dev.02861

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Kurtzeborn K, Kwon HN, Kuure S. MAPK/ERK signaling in regulation of renal differentiation. Int J Mol Sci. (2019) 20. doi: 10.3390/ijms20071779

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Ihermann-Hella A, Lume M, Miinalainen IJ, Pirttiniemi A, Gui Y, Peränen J, et al. Mitogen-activated protein kinase (MAPK) pathway regulates branching by remodeling epithelial cell adhesion. PLoS Genet. (2014) 10:e1004193. doi: 10.1371/journal.pgen.1004193

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Fontanet P, Irala D, Alsina FC, Paratcha G, Ledda F. Pea3 transcription factor family members Etv4 and Etv5 mediate retrograde signaling and axonal growth of DRG sensory neurons in response to NGF. J Neurosci. (2013) 33:15940–51. doi: 10.1523/JNEUROSCI.0928-13.2013

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Chen SR, Liu YX. Regulation of spermatogonial stem cell self-renewal and spermatocyte meiosis by Sertoli cell signaling. Reproduction. (2015) 149:R159–67. doi: 10.1530/REP-14-0481

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, et al. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol. (2009) 26:51–7. doi: 10.1007/s10014-009-0249-9

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Ihermann-Hella A, Hirashima T, Kupari J, Kurtzeborn K, Li H, Kwon HN, et al. Dynamic MAPK/ERK activity sustains nephron progenitors through niche regulation and primes precursors for differentiation. Stem Cell Rep. (2018) 11:912–28. doi: 10.1016/j.stemcr.2018.08.012

PubMed Abstract | CrossRef Full Text | Google Scholar

40. van der Ven AT, Vivante A, Hildebrandt F. Novel insights into the pathogenesis of monogenic congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. (2018) 29:36–50. doi: 10.1681/ASN.2017050561

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Robo2, GEN1, congenital anomalies of the kidney and urinary tract, GDNF/RET, oligo-/polygenic disease

Citation: Li Y, Yu M, Tan L, Xue S, Du X, Wu X, Xu H and Shen Q (2022) Robo2 and Gen1 Coregulate Ureteric Budding by Activating the MAPK/ERK Signaling Pathway in Mice. Front. Med. 8:807898. doi: 10.3389/fmed.2021.807898

Received: 02 November 2021; Accepted: 13 December 2021;
Published: 05 January 2022.

Edited by:

Andrew Mallett, Townsville University Hospital, Australia

Reviewed by:

Jan Halbritter, Leipzig University, Germany
Jennifer Li, The University of Sydney, Australia
Danica Vojisavljevic, James Cook University, Australia

Copyright © 2022 Li, Yu, Tan, Xue, Du, Wu, Xu and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hong Xu, aHh1JiN4MDAwNDA7c2htdS5lZHUuY24=; Qian Shen, c2hlbnFpYW4mI3gwMDA0MDtzaG11LmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.